Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986829 · ClinicalTrials.gov registry record · Phase 2
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT01986829 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 9 participants.
The verdict
NCT01986829, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
This phase II trial studies how well cryoablation, radiofrequency ablation, or microwave ablation works in treating patients with metastatic sarcoma stable on chemotherapy. Cryoablation kills tumor cells by freezing them. Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Microwave ablation kills tumor cells by heating them to several degrees above body temperature.
Interventions
- DEVICE Cryoablation
- DEVICE Microwave ablation
- DEVICE Radiofrequency ablation
- OTHER BPI-Short form
- OTHER FACT-G7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-02-03 |
| Est. Completion | 2017-08-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986829
The ClinicalTrials.gov registry entry for NCT01986829 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cryoablation is the first listed.
NCT01986829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986829 about?
NCT01986829 is a clinical study titled "Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy". This phase II trial studies how well cryoablation, radiofrequency ablation, or microwave ablation works in treating patients with metastatic sarcoma stable on chemotherapy. Cryoablation kills tumor cells by freezing them. Radiofrequency ablation uses a high-frequency, electric current to kill tumor ...
What is the current status of trial NCT01986829?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2014-02-03. Estimated completion is 2017-08-08.
What interventions are being tested in trial NCT01986829?
The interventions under investigation include: Cryoablation (DEVICE), Microwave ablation (DEVICE), Radiofrequency ablation (DEVICE), BPI-Short form (OTHER), FACT-G7 (OTHER).
Who is sponsoring clinical trial NCT01986829?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.